PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF HCV PATIENTS THAT ARE NON-RESPONDERS TO INTERFERON
摘要
The present invention provides compositions and methods of treatment of HCV infected subjects that are not sensitive to Interferon treatment. Further, compositions and methods are provided for prevention of organ transplant rejection. The compositions of the invention comprise an anti microRNA-122 oligonucleotide, and are made for administration to a primate.
申请公布号
WO2010122538(A1)
申请公布日期
2010.10.28
申请号
WO2010IB51822
申请日期
2010.04.26
申请人
SANTARIS PHARMA A/S;HILDEBRANDT-ERIKSEN, ELISABETH;PETRI, ANDREAS;KAUPPINEN, SAKARI;ABRAHAMSEN, NIELS;LANFORD, ROBERT
发明人
HILDEBRANDT-ERIKSEN, ELISABETH;PETRI, ANDREAS;KAUPPINEN, SAKARI;ABRAHAMSEN, NIELS;LANFORD, ROBERT